Indication
Prevention of premature luteinising hormone (LH) surges in women undergoing controlled ovarian hyperstimulation (COH) for assisted reproduction techniques (ART).
Loading your page…
Loading your page…
Reproductive Techniques, Assisted;Ovulation Induction;Infertility, Female
Marketing Authorisation Holder: Chemical Works of Gedeon Richter Plc. (Gedeon Richter Plc.)
EMA Authorisation: 15/07/2022
INN: ganirelix
AI Drug & Interaction Analysis
Free account required
Ask Osler about Ganirelix Gedeon Richter: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.